Phemex Upgrades RPI Ecosystem, Setting New Liquidity Benchmarks Across 210+ Pairs
APIA, Samoa, Dec. 26, 2025 /PRNewswire/ --Â Phemex, a user-first crypto exchange, has…
Conversational English Improvement Startup EnglishYaari Secures 1 Crore Funding at 10 Crore Valuation, Bihar Startup Founders Plan Scaling to 50 cr ARR by 2027
LAKHISARAI, India, Dec. 23, 2025 /PRNewswire/ -- EnglishYaari, a platform to help…
Corti Unlocks “Surgical” AI Improvement, Outperforming Big Tech in Interpretability Benchmark
New "GIM" method tops MIB global leaderboard, offering the industry a scalable…
Dyne Therapeutics Announces Pricing of Upsized $350.0 Million Public Offering of Common Stock
December 09, 2025 21:42 ET Â | Source: Dyne Therapeutics, Inc. WALTHAM, Mass.,…
Halia Therapeutics Announces Positive Phase 2a Data for Ofirnoflast in Lower-Risk MDS at ASH 2025
– New findings demonstrate a 72% HI-E response rate at Week 16…
Built for Better: Srixons New ZXiR Irons Redefine Game Improvement
HUNTINGTON BEACH, Calif., Dec. 4, 2025 – Expanding its acclaimed ZXi Iron…
Hydreight Reports 132% YoY Revenue Increase in Q3 2025 and Fourth Consecutive Quarter of Profitability, Highlighting Strong Multi-Vertical Performance
“The quarter reflects broad growth across all verticals, expanding VSDHOne adoption, and…
Varvee Global Limited (VGL) Posts Strong Operational Profit & EBDITA for Q2FY26: +80% Revenue Growth, 49.8% EBITDA Margin; PAT +23.5% YoY; H1 PAT +15.7% and Attaining Near-Zero Debt
AHMEDABAD, India, Nov. 13, 2025 /PRNewswire/ -- VGL Limited ("VGL" or the…
LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE
Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase…
Innoviti Posts 35% Revenue Growth in FY25
Strong execution across all product lines led to gross margin improvement by…